Free Trial

Avid Bioservices (CDMO) Earnings Date, Estimates & Call Transcripts

Avid Bioservices logo
$12.36 0.00 (0.00%)
(As of 12/17/2024 ET)

Avid Bioservices Latest Earnings Summary

Latest Q1 2025
Earnings Date
Sep. 9Estimated
Actual EPS
(Sep. 9)
-$0.07 Beat By $0.01
Consensus EPS
(Sep. 9)
-$0.08

Avid Bioservices issued Q1 2025 earnings on September 9, 2024, reporting an EPS of -$0.07, which beat the consensus estimate of -$0.08 by $0.01. Quarterly revenue was reported to be $40.17 million, above analysts' expectations of $39.50 million. With a trailing EPS of -$2.39, Avid Bioservices' earnings are expected to grow next year, from ($0.38) to ($0.21) per share.

Get Avid Bioservices Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avid Bioservices and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CDMO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CDMO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avid Bioservices Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.04-$0.04-$0.04
Q2 20241-$0.07-$0.07-$0.07
Q3 20241$0.01$0.01$0.01
Q4 20241$0.03$0.03$0.03
FY 20244-$0.07-$0.07-$0.07
Q2 20251-$0.13-$0.13-$0.13
Q4 20251-$0.06-$0.06-$0.06
20252-$0.19-$0.19-$0.19
Q1 20261-$0.04-$0.04-$0.04
Q2 20261-$0.12-$0.12-$0.12
Q3 20261-$0.03-$0.03-$0.03
Q4 20261$0.01$0.01$0.01
FY 20264($0.18)($0.18)($0.18)

Avid Bioservices Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
9/9/2024Q1 2025-$0.08-$0.07+$0.01-$0.05$39.50M$40.17M
7/2/2024Q4 2024$0.03-$0.07 -$0.10$1.80$42.60M$42.98M
4/24/2024Q3 2024-$0.02-$0.08 -$0.06-$0.07$33.80M$33.82M
12/7/2023Q2 2024-$0.12-$0.15 -$0.03-$0.15$33.55M$25.40M
9/7/2023Q1 2024-$0.04-$0.03+$0.01-$0.03$34.00M$37.73M
6/21/2023Q2 2023-$0.02$0.05+$0.07-$39.00M$39.80M
3/13/2023Q3 2023-$0.08$0.03+$0.11$0.05$36.00M$38.02M

Avid Bioservices Earnings - Frequently Asked Questions

Avid Bioservices (NASDAQ:CDMO) last announced its quarterly earning data on Monday, September 9, 2024. Learn more on CDMO's earnings history.

In the previous quarter, Avid Bioservices (NASDAQ:CDMO) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.01. Learn more on analysts' earnings estimate vs. CDMO's actual earnings.

Avid Bioservices (NASDAQ:CDMO) has a recorded annual revenue of $150.45 million.

Avid Bioservices (NASDAQ:CDMO) has a recorded net income of -$140.75 million. CDMO has generated -$2.39 earnings per share over the last four quarters.

Avid Bioservices's earnings are expected to grow from ($0.38) per share to ($0.21) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CDMO) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners